pentosidine has been researched along with Cognitive Dysfunction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arai, H; Arai, M; Horiuchi, Y; Imai, A; Itokawa, M; Kobori, A; Miyano, Y; Miyashita, M; Nagase, Y; Niizato, K; Nishida, A; Oshima, K; Suzuki, K; Takizawa, S; Toriumi, K; Usami, S; Yamasaki, S; Yoshikawa, A | 1 |
| Borghi, R; Cammarata, S; Monacelli, F; Nencioni, A; Odetti, P; Piccini, A; Tabaton, M | 1 |
2 other study(ies) available for pentosidine and Cognitive Dysfunction
| Article | Year |
|---|---|
Advanced glycation end products and cognitive impairment in schizophrenia.
Topics: Arginine; Cognition; Cognitive Dysfunction; Cross-Sectional Studies; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Neuropsychological Tests; Receptor for Advanced Glycation End Products; Schizophrenia | 2021 |
Amnestic mild cognitive impairment and conversion to Alzheimer's disease: insulin resistance and glycoxidation as early biomarker clusters.
Topics: Aged; Alzheimer Disease; Arginine; Blood Glucose; Case-Control Studies; Cognitive Dysfunction; Disease Progression; Female; Humans; Insulin; Insulin Resistance; Lysine; Male; Malondialdehyde; Neuropsychological Tests; Psychiatric Status Rating Scales; Statistics as Topic | 2015 |